Systematix initiates coverage of Vedanta Aluminium and says the stock could rise by as much as 28%. The brokerage links its view to Vedanta Aluminium’s performance in ramping up its assets in line with guidance. It highlights the company’s progress at Bharat Aluminium Company, Lanjigarh, and Sijimali, as well as the development and use of captive coal mines that support operations. Systematix argues that these steps provide scope for continued earnings improvement, which could also lead to a rerating of the company’s valuation. The articles present the note as an investment research action—an initiation of coverage—rather than news about operational incidents or regulatory developments. Overall, the coverage focuses on expected future financial performance driven by execution of the company’s expansion plans and continued ramp-up progress at its key production and input sites, which the brokerage believes could translate into higher earnings.
Systematix initiates coverage on Vedanta Aluminium, projects potential 28% upside
Systematix initiates coverage of Vedanta Aluminium and says the stock could rise by as much as 28%. The brokerage links its view to Vedanta Aluminium’s performance in ramping up its assets in line wit...
- Systematix initiates coverage on Vedanta Aluminium.
- Systematix projects potential upside of about 28%.
- The brokerage points to Vedanta Aluminium’s asset ramp-up in line with guidance.
- It cites ramp-up progress at Bharat Aluminium Company, Lanjigarh, and Sijimali.
- Systematix expects improved earnings and potential valuation rerating.
Vedanta Aluminium's successful ramp-up of Bharat Aluminium Company, Lanjigarh, Sijimali and captive coal mines as per guidance provides scope for further earnings improvement and a potential rerating,...
10 hours agoVedanta Aluminium's successful ramp-up of Bharat Aluminium Company, Lanjigarh, Sijimali and captive coal mines as per guidance provides scope for further earnings improvement and a potential rerating, says Systematix.
10 hours ago
Molbio Diagnostics IPO sets ₹768–807 price band; issue opens August 10
Molbio Diagnostics Ltd, a point-of-care diagnostics company, has set a public IPO price band of ₹768–₹807 per share. The...
Thomson Reuters reports higher Q2 revenue and raises full-year forecast
Thomson Reuters reports stronger results in its second quarter and lifts its full-year outlook. According to the reporte...
Photronics (PLAB) Faces Securities Class Action With September 4, 2026 Lead Plaintiff Deadline
Multiple law-firm notices report that Photronics, Inc. (NASDAQ: PLAB) is facing a securities class action alleging viola...